
Venture capitalist, born in 1994, who backs biological research to slow or reverse aging.
Inside Vertex's first years: how a new drug company tries to discover a drug.
How Genentech turned genetic engineering into a company, from its founders' accounts.
Also recommended by: Patrick Collison
How Joshua Boger left Merck to found a drug company to take on the giants.
| What it’s like to be 28 | ldeming | Blog post | 2022-06-30 |
| Transcendent Joy | ldeming | Blog post | 2022-04-09 |
| Aubrey | ldeming | Blog post | 2021-08-10 |
| Understanding biology, quickly | ldeming | Blog post | 2021-03-24 |
| Immortal Yeast: a week's worth of research | ldeming | Blog post | 2021-01-23 |
| Call for playtesters: Tiny Machines - a portal to quantitative biology | ldeming | Blog post | 2020-10-19 |
| Tips for newcomers to longevity biotech | ldeming | Blog post | 2020-10-15 |
| Why are we so much bigger than atoms? | ldeming | Blog post | 2020-10-06 |
| I'm looking for a thought partner | ldeming | Blog post | 2020-09-04 |
| Can someone build Roam x Mathematica? | ldeming | Blog post | 2020-08-29 |
| How not to be sad | ldeming | Blog post | 2020-06-21 |
| Advice for ambitious teenagers | ldeming | Blog post | 2020-06-15 |
| The Rage of Research | ldeming | Blog post | 2020-05-24 |
| Sequencing is the new microscope | ldeming | Blog post | 2018-11-05 |
| She Raised $100M+ to Reversibly Cryopreserve Humans — Laura Deming (Until) | The Luba Show | 2026-07-30 | 1:02 | Today I walk with Laura Deming, co-founder of Until, a reverse cryopreservation company in San Francisco. Laura got interested in longevity at eight, started working in Cynthia Kenyon's lab at UCSF at 12, and spent years backing the field as an investor through the Longevity Fund. She now builds technology to pause biological time, starting with donor organs and building toward whole-body medical hibernation. We get into: -The conference talk she was not supposed to give, and how it ended her VC chapter -What "transcend death" actually means once you press on it, tested with a teleporter to Mars -Why San Francisco kills intuition, and the breakdown in her mid-20s that made her protect hers -The big magnet, and rewarming an organ in about a minute -Why transplant patients live inside a two-hour radius with a pager on them at all times so much more! |
| Why Cryopreservation is No Longer Science Fiction with Until Co-founder and CEO Laura Deming | No Priors: Artificial Intelligence | Technology | Startups | 2026-01-29 | 31 min | What if we could pause biological time to wait for a cure for a disease? Thanks to innovations and research in reversible cryopreservation, this possibility is no longer just science fiction. Sarah Guo sits down with Laura Deming, CEO and co-founder of biotech startup Until, to dive deep into the growing field of reversible cryopreservation. Laura talks about how her time as a Thiel Fellow as well as her founding of the Longevity Fund fueled her obsession with solving the “social blindspot” of aging. Laura details how her new startup, Until, seeks to build tools that allow for “pressing pause” on biological time, starting with human organs with the hopes of scaling up to full body medical hibernation. Together, they also discuss why ice is the enemy of tissue, using engineering tools to help solve biological problems, and how this technology may revolutionize organ transplantation by removing time as a variable. Sign up for new podcasts every week. |
| Laura Deming — On Pausing Biological Time & Preserving the Continuous Self | The Joe Walker Podcast | 2025-05-20 | 1:17 | Laura Deming is a technologist and venture capitalist focused on anti-ageing and life extension. At 17, she founded The Longevity Fund (followed by age1), the first VC firm dedicated to longevity biotech, after being selected in the initial cohort of Thiel fellows (2011). Today she is also CEO and co-founder of Cradle, a startup pursuing human whole-body reversible cryopreservation. I speak with Laura at Cradle’s San Francisco office. We start with the philosophical question of personal identity, and ask a deceptively simple question: what, exactly, do we want to preserve? From there we explore what a “more humane transhumanism” might look like, the game-theory of 200-year lives, scientific awe as a research tool, embodied thought-experiments to see inside the cell, how the FDA could shave years off longevity-drug timelines, the anti-memetic qualities of reversible cryopreservation, and why it might be the most leveraged problem in longevity. See omnystudio.com/listener for privacy information. |
| E52: Charting the Course of Biotech with Laura Deming, GP of Longevity Fund, and Will Eden of Sylvan Consulting | "Turpentine VC" | Venture Capital and Investing | 2024-08-20 | 1:23 | This week on Turpentine VC, we’re releasing a conversation between Erik Torenberg, Laura Deming of The Longevity Fund and Will Eden of Sylvan Consulting (prior to that, with Thiel capital) focused on the past, present and future of biotech. Recorded in 2019, they discuss platform companies and the evolving biotech investment landscape, examining segments like therapeutics, cell and gene therapies. Will and Laura share insights on the historical waves of biotech, the FDA's role, and the intersections of biotech and tech investment strategies. They address challenges in evaluating biotech startups, the growth in longevity research since 2011, and the potential for extending life spans through various scientific advancements. 🔥 Apply to join over 400 founders and Execs in the Turpentine Network: https://hmplogxqz0y.typeform.com/to/JCkphVqj — RECOMMENDED PODCASTS: 🎙️ This Won't Last - Eavesdrop on Keith Rabois, Kevin Ryan, Logan Bartlett, and Zach Weinberg's monthly backchannel. They unpack their hottest takes on the future of tech, business, venture, investing, and politics. Apple Podcasts: https://podcasts.apple.com/us/podcast/id1765665937 Spotify: https://open.spotify.com/show/2HwSNeVLL1MXy0RjFPyOSz YouTube: https://www.youtube.com/@ThisWontLastpodcast — SPONSORS: 🛠️ Building an enterprise-ready SaaS app? WorkOS has got you covered with easy-to-integrate APIs for SAML, SCIM, and more. |
| The science that could keep us healthy in our 80s and beyond | Laura Deming | 80,000 Hours Podcast | 2024-03-01 | 1:37 | "The question I care about is: What do I want to do? Like, when I'm 80, how strong do I want to be? OK, and then if I want to be that strong, how well do my muscles have to work? OK, and then if that's true, what would they have to look like at the cellular level for that to be true? Then what do we have to do to make that happen? In my head, it's much more about agency and what choice do I have over my health. And even if I live the same number of years, can I live as an 80-year-old running every day happily with my grandkids?" — Laura Deming In today’s episode, host Luisa Rodriguez speaks to Laura Deming — founder of The Longevity Fund — about the challenge of ending ageing. Links to learn more, summary, and full transcript. They cover: How lifespan is surprisingly easy to manipulate in animals, which suggests human longevity could be increased too. Why we irrationally accept age-related health decline as inevitable. The engineering mindset Laura takes to solving the problem of ageing. Laura’s thoughts on how ending ageing is primarily a social challenge, not a scientific one. The recent exciting regulatory breakthrough for an anti-ageing drug for dogs. Laura’s vision for how increased longevity could positively transform society by giving humans agency over when and how they age. Why this decade may be the most important decade ever for making progress on anti-ageing research. The beauty and fascination of biology, which makes it such a compelling field to work in. |
| Laura Deming on living forever, contrarian thinking, homeschooling, beauty of mathematics and funding longevity research | The Aarthi and Sriram Show | 2022-09-01 | 1:25 | In this episode of The Good Time Show, Aarthi and Sriram interviewed Laura Deming. Laura Deming is a partner at and founder of The Longevity Fund, a venture capital firm focused on aging and life extension. At age 8, Deming became interested in the biology of aging, and at age 12 she joined the lab of Cynthia Kenyon at the University of California, San Francisco. Deming was accepted to MIT at age 14 and later dropped out to accept the Thiel Fellowship and start a venture capital firm. We covered topics on aging, longevity research, the philosophical implications of living 'forever', contrarian thinking, beauty of mathematics (and the number 28), homeschooling and why research funding is a popularity contest now. Follow Sriram: https://www.instagram.com/sriramk/ https://twitter.com/sriramk Follow Aarthi: https://www.instagram.com/aarthir/ https://twitter.com/aarthir Follow the podcast: https://www.instagram.com/aarthiandsriramshow/ https://twitter.com/aarthisrirampod |
| Laura Deming: Solving Immortality | Longevity, Venture Capital, Life Science and Biotech | The Quest Pod with Justin Kan | 2021-05-25 | 51 min | Laura Deming is not your typical VC. She is the founder and partner of The Longevity Fund, a venture capital firm focused on the study of aging and life extension in humans. Home-schooled in New Zealand, she moved to the U.S with her family to work in an age genetics lab at just twelve years old before dropping out of MIT at fourteen following her acceptance as a Thiel Fellow. In this episode, Laura and I discuss her journey to become an effective leader, taking risks, dealing with failure, and being motivated to change the world for a better place. Beyond her impressive resume, she is a reminder that great founders can come from anywhere, so long as you have the passion to pursue something relentlessly and are not afraid to step outside your comfort zone. If you are interested in discussions about pushing the boundaries of science, technology, and concepts of biological immortality, you definitely don’t want to miss this episode. You can find Laura on Twitter and check out her blog here . 📺 Experience The Quest Pod in 4K: https://youtube.com/c/TheQuestwithJustinKan 🍎 iTunes: https://apple.co/3lU3fZs 🎵 Spotify: https://spoti.fi/3srzJwq ✍️ The Quest Pod in print: https://thequest.media 🌎 Everything Quest: https://bio.thequest.media |
| Digital Salon with Laura Deming: Self-Education and the State of Longevity | Palladium Podcast | 2020-10-13 | 1:25 | Laura Deming joins the salon to speak with Wolf Tivy and Ash Milton about education, where talent comes from, and the state of longevity research. Discussion topics included how to cultivate talent, where the most fruitful life extension research is happening, and whether intellectually productive communities are necessarily doomed to stagnation. Laura Deming is the founder of The Longevity Fund, a Venture Capital firm that focuses on life extension. She was homeschooled in New Zealand, taught herself mathematics, literature, and history, and was working in a biological research lab on aging research by age 12. She was accepted to MIT at age 14, but later dropped out for the Thiel Fellowship. |
| Interview with LAURA DEMING, Mom of Special Needs Child | RIGHT NOW Spotlight S7 Ep10 | NRN+ | RIGHT NOW Podcast | 2020-07-29 | 20 min | RIGHT NOW Spotlight, NRN+ Original Series where various members of NRN interview the top conservative politicos and people of interest. Right Voice. Right Now. https://NRNplus.com/spotlight Laura Deming proudly served her country as a Navy veteran and is currently an Advanced Practice Registered Nurse that treats and advocates for autistic and other special needs children, including and especially her 14 year old son Beau, who very much just wants to go back to school.. - Aired on July 23, 2020 ➜ Become an NRN+ member https://NRNplus.com ➜ Subscribe on Youtube https://bit.ly/2tRQNCG ➜ Join RIGHT NOW Newsletter https://newrightnetwork.com/email NRN broadcasts on-demand programming produced by a dynamic community-based network - everyday individuals and experienced reporters broadcasting their lives and values of faith, family, and freedom. NRN partners with a range of freethinkers; everything they and their guests say may not reflect the views of NRN and their hosts. |
| The Past, Present, and Future of Biotech and Longevity with Laura Deming and Will Eden | Village Global Podcast | 2019-09-26 | 1:22 | Joining Erik on this episode are Laura Deming (@laurademing), creator of Longevity Fund, and Will Eden (@williamaeden), entrepreneur in residence with Errik Anderson at Ulysses and formerly of Thiel Capital. They talk about: - The history of biotech and the big trends and companies in the space over the past several decades. - The breakdown of the different areas within biotech. - The new business model in biotech that’s been driven by VCs. - How the public market in biotech companies is impacting the private market - The history of the FDA and how it has evolved over time, including the fact that in the beginning, the FDA only looked at whether a drug was safe, not whether it was effective. - How they would change the regulatory environment if they could wave a magic wand. - Why Laura says that the most effective individuals in biotech have a determinate worldview. - How longevity has emerged over the past several years, and the future of work in the space. Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at villageglobal.vc or get in touch with us on Twitter @villageglobal. Venture Stories is brought to you by Village Global and is hosted by co-founder and partner, Erik Torenberg. Grace Chen is our audio engineer and the show is produced by Brett Bolkowy. |
| The Present and Future of Longevity with Laura Deming | Village Global Podcast | 2018-12-17 | 54 min | Laura Deming (@laurademing) joins Erik in downtown San Francisco on this episode of Venture Stories. She is the creator of Longevity Fund, a venture capital firm investing in companies that will let humans live both longer and healthier. Erik starts by asking about the state of longevity science and which discoveries about aging Laura is most excited about. It turns out that certain animals don’t age the way that humans do and that there are certain animals that are similar to each other (like rats and naked mole rats) that nevertheless have wildly different life expectancies. These discoveries have Laura very excited about the possibilities for extending the human lifespan — in fact, she compares them to “finding gold in your living room” and says they don’t get enough attention. They talk about why creating a venture fund is the best way for Laura to make an impact on this problem as well as the realities of venture funding in the life sciences space. Laura explains why returns are so important. Erik asks how those of us who are not scientists can get involved in the space and which companies Laura is most excited about. She also runs through some of her requests for startups in the field. Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at villageglobal.vc or get in touch with us on Twitter @villageglobal. |
| 20VC: Why Raising A First Time Fund Is Like Raising A Seed Round, Why We Need New and Different Fund Models & Why Longevity Is The Most Rewarding Place To Invest with Laura Deming, Founding Partner @ The Longevity Fund | The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch | 2018-11-26 | 30 min | Laura Deming is Founding Partner @ The Longevity Fund , the first VC firm dedicated to funding high-potential longevity companies. To date, Laura has raised $26m across 2 Longevity funds and has backed the likes of Unity Biotechnology , Precision Biosciences , Metacrine , Navitor , and Alexo Therapeutics . Prior to Longevity, Laura was accepted to MIT at the age of 14 to study physics and then dropped out to join the Thiel Fellowship and start The Longevity Fund. If that wasn't enough, Laura most recently founded Age1, a four-month startup accelerator program focused on founders creating longevity companies. In Today's Episode You Will Learn: 1.) How Laura made her way from studying physics at MIT at just 14 to founding The Longevity Fund and dropping out to join The Thiel Fellowship? 2.) As a 16-year-old, looking to raise a fund to invest in longevity, how was the fundraise process for Laura? Why does Laura believe that raising your first fund is very much like raising a seed round for a company? What was the catalytic moment when the fundraise started to come together? What were the biggest challenges of the raise? 3.) Why does Laura believe that there is a shortage of young biotech founders today? What can be done to solve this and increase pipe? How does Laura find biotech founders compare to more traditional consumer and B2B founders she engages with? How does what they look for from their investor base differ? 4.) |
| 'DEPLORABLE FRAGRANCE' / Fun Holiday Week Segment / Laura Deming & Timothy Shea | Catalog of Interviews and Bits | 2018-11-26 | The idea came easy for former Navy Officer Laura Deming. After hearing Hillary Clinton called Trump supporters “a basket of deplorables” she new it was time to act. That was followed by Peter Strzok texting his friend Lisa Page, “I’m in a Walmart in Southern Virginia and I can just smell the Trump support”. Thus was born - 'Deplorable Fragrances' (www.cult45llc.com). "I figured I'd create a scent to go with the Trump movement," says Deming. Now she and her business partner, and former host of 'RedNationRising', Timothy Shea are selling 'Deplorable' & 'Deplorable Dude' perfume and cologne coast to coast (see short client bios below). "We needed to make sure the Trump support we are seeing also had a fragrance that every liberal could smell," says Shea. "With Deplorable & Deplorable Dude' we have such a scent and one that's a perfect Christmas gift for the Trump supporter in your family." Cult45 LLC., is a veteran own business and 'Deplorable' and 'Deplorable Dude' fragrances are made entirely in the USA. SUGGESTED QUESTIONS: How did the two of you get the idea? What's it smell like? Why it's the perfect gift for Trump supporters? Why it's important that it's made in the USA MEET ENTREPRENEURS LAURA & TIMOTHY Laura Deming is a former Navy Officer (LT); the widowed single mother of a teenage daughter and a 12-year-old son, who has autism; a breast cancer survivor; a nurse practitioner helping parents with special needs children, and someone who simply has no quit in her. | |
| #99 - Laura Deming | Y Combinator Startup Podcast | 2018-10-23 | 1:10 | Laura Deming is a partner at The Longevity Fund . They invest in companies that will allow us to live longer and healthier lives. You can learn more about them at Longevity.vc . Laura’s on Twitter @LauraDeming . The YC podcast is hosted by Craig Cannon . *** Topics 00:22 - Why focus on longevity now? 2:12 - How did Laura get started in longevity? 3:22 - Why raise a fund? 5:52 - What does Laura do personally for longevity? 9:07 - Worm and mouse studies 10:44 - Craig's personal habits 12:37 - Human studies 15:22 - Mica asks - Do you think immortality is going to be achieved by: 1. Curing all disease and stop aging so we could live with our own bodies forever 2. OR is going to be something like porting our brain, "mind" to a computer/robot? 17:37 - Most likely strategies to increase lifespan 19:47 - Ryan Hoover asks - Ask about the ethics of longevity. Jack J. Fernandes asks - Do people actually want to live longer? 21:44 - Mica asks - How would immortality change society? Wouldn't we become more complacent? Since we have "forever" to do things wouldn't that diminish our rate of innovation? And since less new individuals are being created we would have access to less new ideas. We would just stop creating new Newtons, Einsteins, Mozarts… 24:52 - Cognitive enhancement 25:52 - Daily habits 34:12 - Tech environment changes in the past 5-10 years 39:22 - What percentage of people in labs want to start companies? |
| Finding the world's 'lost Einsteins' and the end of aging | Product Hunt Radio | 2018-09-26 | 45 min | In this episode of Product Hunt Radio I'm joined by two incredible people, Laura Deming and Daniel Gross , who have accomplished more before the age of 30 than most people have realized in a lifetime. Laura grew up in New Zealand and came to San Francisco when she was only 12 years old to join a lab studying aging. She was accepted to MIT at 14 before leaving to form Longevity Fund , a venture capital firm investing in companies aimed to help us all live longer and healthier lives. Daniel came to the Bay Area from Israel, accepted into Y Combinator in 2010, the youngest founder to go through the program at that time. His startup, Cue, was later acquired by Apple which led him to a leadership position across a number of AI and machine learning teams at the company. He left Apple to work at Y Combinator and recently launched Pioneer , a program to identify and support brilliant people in the world. In this episode we talk about: What it was like for Laura and Daniel to move to the Bay Area from overseas. How Pioneer is aimed to find the “world's lost Einsteins, Marie Curies and Elon Musks”. Why some animals don't age and how humans might be able to learn from creatures such as the tortoise or the naked mole rat. The challenges posed by living much longer than humans do now and how society might change as a result. Why you should sometimes call what you're creating on a project or experiment, rather than a startup. How to find your passion through experimentation. |
| An Interview with Venture Capitalist, Laura Deming | Mission Daily | 2018-08-27 | 26 min | Chad sits down with venture capitalist and scientist Laura Deming. Together they discuss Laura’s past as a scientist and how she got her start funding organizations that help prevent aging. Today’s episode of The Mission Daily is brought to you by Twilio. More than 2 million developers around the world have used Twilio to unlock the magic of communications. This October, Twilio is hosting SIGNAL, the customer and developer conference of the year. The Mission Daily listeners receive 20% off tickets when going to signal.twilio.com and using code MISSION20. The Mission publishes the#1 newsletter for accelerated learning each day on Monday through Friday. Join hundreds of thousands of subscribers at: www.TheMission.co/subscribe You can follow us on Twitter or Instagram @TheMissionHQ The Mission Studios creates custom podcasts and sponsorships for world-class companies like Salesforce, Twilio, and Katerra. Our campaigns are customized to help accomplish your biggest goals for the year. So whether you need to reach a few dozen C-Level decision makers (we’ve done that) or get your logo and brand 8M+ impressions in ~3 months (we’ve done that too!) we would love to help! To connect with our world-class team of creatives, please reach out here or email Ian@TheMission.co Email us -> info@mission.org Work with us -> https://www.missionsponsors.com/ Follow Stephanie -> https://www.linkedin.com/in/stephaniepostles/ Hosted by Simplecast, an AdsWizz company. |
| The Science of Pausing and Reversing Aging | Laura Deming and Jacob Kimmel | Kleiner Perkins | |||
| Laura Deming & Hunter Davis: A Tractable Approach to Reversible Cryopreservation | S3 | Science, Startups, & Stories | |||
| She Dropped Out of MIT at 16 to Reverse Ageing @Laura Deming | The Quest Pod | Fractal Radio | |||
| Building longevity startups with Laura Deming, founder of Longevity Fund | Bay Bridge Bio | |||
| Good For You with Laura Deming, Arvind Gupta, Nina Kjellson | TechCrunch |
TShe Raised $100M+ to Reversibly Cryopreserve Humans — Laura Deming (Until)The Luba Show · 2026-07-30
NWhy Cryopreservation is No Longer Science Fiction with Until Co-founder and CEO Laura DemingNo Priors: Artificial Intelligence | Technology | Startups · 2026-01-29
TLaura Deming — On Pausing Biological Time & Preserving the Continuous SelfThe Joe Walker Podcast · 2025-05-20
"E52: Charting the Course of Biotech with Laura Deming, GP of Longevity Fund, and Will Eden of Sylvan Consulting"Turpentine VC" | Venture Capital and Investing · 2024-08-20
8The science that could keep us healthy in our 80s and beyond | Laura Deming80,000 Hours Podcast · 2024-03-01
TLaura Deming: Solving Immortality | Longevity, Venture Capital, Life Science and BiotechThe Quest Pod with Justin Kan · 2021-05-25
VThe Past, Present, and Future of Biotech and Longevity with Laura Deming and Will EdenVillage Global Podcast · 2019-09-26
VThe Present and Future of Longevity with Laura DemingVillage Global Podcast · 2018-12-17
T20VC: Why Raising A First Time Fund Is Like Raising A Seed Round, Why We Need New and Different Fund Models & Why Longevity Is The Most Rewarding Place To Invest with Laura Deming, Founding Partner @ The Longevity FundThe Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch · 2018-11-26
Y#99 - Laura DemingY Combinator Startup Podcast · 2018-10-23
PFinding the world's 'lost Einsteins' and the end of agingProduct Hunt Radio · 2018-09-26
MAn Interview with Venture Capitalist, Laura DemingMission Daily · 2018-08-27
KThe Science of Pausing and Reversing Aging | Laura Deming and Jacob KimmelKleiner Perkins
SLaura Deming & Hunter Davis: A Tractable Approach to Reversible CryopreservationS3 | Science, Startups, & Stories
FShe Dropped Out of MIT at 16 to Reverse Ageing @Laura Deming | The Quest PodFractal Radio
BBuilding longevity startups with Laura Deming, founder of Longevity FundBay Bridge Bio
TGood For You with Laura Deming, Arvind Gupta, Nina KjellsonTechCrunch